Australia markets closed

Eastwood Bio-Medical Canada Inc. (EBM.V)

TSXV - TSXV Real-time price. Currency in CAD
Add to watchlist
0.60000.0000 (0.00%)
At close: 02:44PM EDT
Currency in CAD

Valuation measures4

Market cap (intra-day) 41.33M
Enterprise value 41.38M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)56.10
Price/book (mrq)N/A
Enterprise value/revenue 56.16
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.53
52-week change 3-40.00%
S&P500 52-week change 323.49%
52-week high 31.1000
52-week low 30.4000
50-day moving average 30.7386
200-day moving average 30.6951

Share statistics

Avg vol (3-month) 3765
Avg vol (10-day) 3600
Shares outstanding 568.89M
Implied shares outstanding 668.89M
Float 820.95M
% held by insiders 169.55%
% held by institutions 10.00%
Shares short (15 May 2024) 493
Short ratio (15 May 2024) 40.61
Short % of float (15 May 2024) 4N/A
Short % of shares outstanding (15 May 2024) 40.00%
Shares short (prior month 28 Mar 2024) 456

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Oct 2023
Most-recent quarter (mrq)31 Jan 2024

Profitability

Profit margin -72.15%
Operating margin (ttm)-31.25%

Management effectiveness

Return on assets (ttm)-64.96%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)736.75k
Revenue per share (ttm)0.01
Quarterly revenue growth (yoy)-39.50%
Gross profit (ttm)N/A
EBITDA -436.37k
Net income avi to common (ttm)-531.6k
Diluted EPS (ttm)-0.0100
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)6.02k
Total cash per share (mrq)0
Total debt (mrq)51.89k
Total debt/equity (mrq)N/A
Current ratio (mrq)0.07
Book value per share (mrq)-0.01

Cash flow statement

Operating cash flow (ttm)-7.53k
Levered free cash flow (ttm)180.07k